Mridula A. George

Mridula George practices at Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health.

Mridula George's NPI, 1285997569, was assigned on June 21, 2012. Mridula George graduated from Rutgers New Jersey Medical School in 2012. Mridula George holds New Jersey license 25MA09724500.

Mridula George's primary practice is Robert Wood Johnson University Hospital, at One Robert Wood Johnson Place, New Brunswick, NJ 08901 in Middlesex County. The practice phone is (732) 828-3000. Mridula George also practices at Robert Wood Johnson University Hospital - New Brunswick, 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901.

Mridula George's primary practice is Robert Wood Johnson University Hospital in New Brunswick, New Jersey, part of RWJBarnabas Health. The medical group on file is Rutgers-RWJ Scleroderma Program. Dmand AI also links Mridula George to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mridula George practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Mridula George's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Mridula George's licenses on file in 2 states: New Jersey and Massachusetts.

Dmand AI lists multiple myeloma among the conditions Mridula George treats.

CMS data shows 385 Medicare services from Mridula George across 6 procedure codes in 2024, for 129 Medicare patients. Medicare paid $29,656 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 129 Medicare patients who saw Mridula George in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have cancer, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mridula George's median patient age at 65, with 96% women.

In 2024, Mridula George wrote 523 Medicare Part D claims for 157 patients. 87% of them were for generic drugs. CMS names the drug for 447 of them, across 9 drugs with 11 or more claims each, at $746,971 in total drug cost. In 2023, CMS named 368 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Mridula George for performance year 2024, reported as part of a group. Mridula George accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Mridula George, published from 2020 to 2024. 2022 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Radiotherapy, Adjuvant and Chemotherapy, Adjuvant. Mridula George has published most often in Breast Cancer Res Treat. Mridula George's most frequent co-authors are Bruce G. Haffty, MD, Shicha Kumar, MD and Nisha Ohri, MD.

Dmand AI links Mridula George to 5 clinical trials, 2 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Triple Negative Breast Neoplasms. Seagen, a wholly owned subsidiary of Pfizer sponsors the most, 2. Open Payments lists research payments to Mridula George that name 1 trial.

CMS Open Payments shows 54 general payments to Mridula George from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Genentech, Inc. paid the most, $3,612. It also lists 1 research payment totaling $3,084 in 2023, naming 1 clinical trial.

Mridula George graduated from Rutgers New Jersey Medical School in 2012.

Mridula George is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.